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Understanding Natural Killer (NK) cell anatomical distribution is key to dissect the role of
these unconventional lymphocytes in physiological and disease conditions. In mouse, NK
cells have been detected in various lymphoid and non-lymphoid organs, while in humans
the current knowledge of NK cell distribution at steady state is mainly restricted to lym-
phoid tissues. The translation to humans of findings obtained in mice is facilitated by the
identification of NK cell markers conserved between these two species.The Natural Cyto-
toxicity Receptor (NCR) NKp46 is a marker of the NK cell lineage evolutionary conserved
in mammals. In mice, NKp46 is also present on rare T cell subsets and on a subset
of gut Innate Lymphoid Cells (ILCs) expressing the retinoic acid receptor-related orphan
receptor γt (RORγt) transcription factor. Here, we documented the distribution and the
phenotype of human NKp46+ cells in lymphoid and non-lymphoid tissues isolated from
healthy donors. Human NKp46+ cells were found in splenic red pulp, in lymph nodes,
in lungs, and gut lamina propria, thus mirroring mouse NKp46+ cell distribution. We also
identified a novel cell subset of CD56dimNKp46low cells that includes RORγt+ ILCs with
a lineage−CD94−CD117brightCD127bright phenotype.The use of NKp46 thus contributes to
establish the basis for analyzing quantitative and qualitative changes of NK cell and ILC
subsets in human diseases.
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INTRODUCTION
Originally assigned to the innate immune system, Natural Killer
(NK) cells recently revealed adaptive properties (Paust and von
Andrian, 2011; Sun and Lanier, 2011; Vivier et al., 2011). Beside
their unique ability to exert natural and antibody-dependent
cell cytotoxicity (ADCC), NK cells secrete various cytokines and
chemokines, thus shaping both innate and adaptive immune
responses (Vivier et al., 2008). Consistent with their patrolling
role during early immune responses, NK cells are broadly distrib-
uted in the mouse in both lymphoid (e.g., peripheral blood, lymph
nodes, spleen, and bone marrow) and non-lymphoid organs (e.g.,
liver, lung, uterus, skin, and gut; Shi et al., 2011). Distinct combina-
tions of homing and chemotactic G-protein coupled receptors are
acquired by NK cells during their maturation process, thus regu-
lating their trafficking within the body (Walzer and Vivier, 2011).
The quantity of NK cells depend upon the organ analyzed. NK
cells can also acquire tissue-specific functions, as postulated for
uterine NK cells during placentation process (Hanna et al., 2006).
Infiltrating cells expressing NK receptors (NKR) have been
detected in tissues of patients suffering from diverse inflamma-
tory disorders, prompting to investigate the role of NK cells in
these situations (Schleinitz et al., 2010). However, quantitative
and qualitative changes of NK cells that can be associated with
disease conditions cannot be properly evaluated without a precise
knowledge of NK cell tissue distribution at steady state. Currently,
human NK cells have been mainly studied in lymphoid tissues,
restricting the knowledge of their distribution in non-lymphoid
tissues to extrapolation from studies in the mouse model (Shi et al.,
2011). One of the limitations to extend these studies to humans
resides in the poor availability of healthy human tissues, in partic-
ular non-lymphoid ones. Another major limitation to translation
of findings obtained in mice to humans has been represented for
a long time by the absence of markers conserved between mice
and humans. Indeed, human NK cells express an array of either
inhibitory or activating receptors undergoing high rate of evolu-
tion, even when compared to high-related chimpanzees (Parham
et al., 2012), and that is quite different from that expressed by
mouse NK cells (Vivier et al., 2008). The Natural Cytotoxicity
Receptor (NCR) encompass three molecules initially described
in human NK cells: NKp30, NKp44, and NKp46. While NKp44
expression is mainly restricted to primates, NKp30 is present also
on rat NK cells (Hsieh et al., 2006) and NKp46 is evolutionary
conserved in mammals, thus representing the best candidate to
identify NK cells in various mammalian species (Walzer et al.,
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2007b). However, in mice NKp46 can be also found on rare T
cell subsets (Stewart et al., 2007; Walzer et al., 2007a) as well as
on some gut Innate Lymphoid Cells (ILCs) cell subsets express-
ing the retinoic acid receptor-related orphan receptor γt (RORγt)
transcription factor (Satoh-Takayama et al., 2008; Luci et al., 2009;
Sanos et al., 2009). We collected the samples of both lymphoid and
non-lymphoid organs isolated from human brain-dead donors,
and analyzed the distribution and the phenotype of NKp46+ cells
in various healthy human tissues.
RESULTS
TISSUE DISTRIBUTION OF NKp46+ CELLS IN HUMAN HEALTHY
LYMPHOID AND NON-LYMPHOID TISSUES
We first investigated the distribution of NKp46+ cells in tissue
sections of various lymphoid and non-lymphoid organs prepared
from healthy individuals. In the spleen, the splenic white pulp
(WP) is constituted by the T cell zone and B-cell follicles sur-
rounding splenic central arterioles (Mebius and Kraal, 2005). WP
lymphoid structures are disseminated within the red pulp (RP),
containing abundant macrophages or dendritic cells expressing
the Macrophage Mannose Receptor-1/CD206 molecule and lin-
ing splenic venous sinuses (Pack et al., 2008). NKp46+ cells were
rare within organized CD3+ T cell and CD20+ B-cell lymphoid
zones (Figure 1). Most NKp46+ cells were present as scattered
cells in CD206+ RP areas surrounding WP lymphoid structures
(Figure 1). The large majority of CD3−NKp46+ cells were CD56+
(Figures 2A and 3). These findings show that human splenic
NKp46+ cells mainly localize in the RP at steady state, as in mouse
model (Gregoire et al., 2008). In this organ, the selective expres-
sion of NKp46 expression to NK cells was confirmed by the barely
detectable presence of T cells expressing NKp46, which contrasts
with the expression of CD56 on 2–8% of CD3+ cells (Figures 2A
and 3).
We then analyzed the distribution of NKp46+ cells in human
small and large intestine. Consistent with our previous findings
(Luci et al., 2009), NKp46+ cells were mainly detectable within the
lamina propria of ileum villi (Figures 4A,B) and of colonic crypts
(Figures 4C and 5, inset 1). CD56, the Neural Cell Adhesion mol-
ecule (N-CAM) has been used since decades to identify NK cells
in humans. In the gut, CD56 stained numerous CD45− cells (data
not shown), most likely corresponding to N-CAM+ nervous fibers
(Driessen et al., 1995), and preventing the unambiguous identi-
fication of CD56+NKp46+ cells in the gut (Figure 2B). Within
epithelial cell layer, we detected rare NKp46+CD3− (Figure 5,
inset 2) and NKp46+CD3+ cells (Figure 5, inset 3). NKp46+ cells
were also found in colonic lymphoid aggregates enriched in T and
FIGURE 1 | Distribution of NKp46+ cells in the spleen. (A–D) Frozen
sections of human spleen were stained with polyclonal anti-NKp46
serum (green), anti-CD20 mAb (red), and anti-CD3 mAb (blue) (A,B) or
with polyclonal anti-NKp46 serum (green), anti-CD206 mAb (red), and
anti-CD3 mAb (blue) (C,D). WP, white pulp; RP, red pulp. Arrows
indicate NKp46+CD3− cells. Scale bar=50µm. Data are representative
of at least two independent experiments performed on three distinct
individuals.
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FIGURE 2 | Staining with anti-NKp46, anti-CD56, and anti-CD3 in human
spleen and gut. (A,B) Frozen sections of human spleen (A) or colon (B) were
stained with polyclonal anti-NKp46 serum (green), anti-CD56 mAb (red), and
anti-CD3 mAb (blue). Nuclei were counterstained with Sytox (gray). Scale
bar=50µm. Data are representative of at least two independent
experiments performed on three distinct individuals.
FIGURE 3 | Quantification of splenic cells expressing CD56, NKp46, or
CD3. Cells with indicated phenotypes were quantified on human spleen
sections. Data (mean±SEM) are representative of three distinct
individuals. Corresponding values (mean±SEM) are indicated at the top of
the corresponding bars. Counting of the indicated cell subsets was
performed in 2–5 distinct areas of tissue sections.
B lymphocytes (Figure 4D). This localization was reminiscent
of NKp46+ cells expressing the RORγt transcription factor and
present in gut-associated lymphoid tissues in the mouse (Sanos
et al., 2009; Vivier et al., 2009; Reynders et al., 2011).
EXPRESSION OF NKp46 ON GUT RORγT+ CELLS
In mouse gut-associated lymphoid tissues, the differential expres-
sion of the RORγt transcription factor discriminates two NKp46+
cell subsets: the NKp46+RORγt+, a subset of ILCs that produces
IL-22, and conventional NKp46+RORγt− cells (cNK cells), that
produces IFN-γ (Satoh-Takayama et al., 2008; Luci et al., 2009;
Sanos et al., 2009; Reynders et al., 2011). We thus investigated
whether human gut NKp46+ expressed RORγt. Scarced RORγt+
cells were found in the gut lamina propria. These cells expressed
the c-kit receptor, CD117 (Figure 6A) and were largely CD3−
(Figure 6B), consistent with their classification as RORγt+ILCs
(Cupedo et al., 2009; Crellin et al., 2010). RORγt+CD117+ cells
were found to be NKp46− (Figure 6A, inset 1) or NKp46low
(Figure 6A, inset 2). Subsets of RORγt+ILCs present in human
tonsils can express other NK cell markers, such as CD56 (Cupedo
et al., 2009; Crellin et al., 2010). However, the use of this marker
in histology was not applicable to intestinal tissues (Figure 2B).
Our results thus indicate that, differently from the mouse model,
NKp46 is barely detectable on human gut RORγt+CD117+ ILCs
in histology. Thus, either NKp46+RORγt+ cells are not present in
human, or their cell surface expression of NKp46 is too low to be
unambiguously visualized in tissue sections. These data also imply
that the vast majority of NKp46+CD3− cells readily detected by
immunohistology in gut lamina propria and lymphoid aggregates
are cNK cells.
EXPRESSION OF CD56 AND NKp46 IN LYMPHOID AND NON-LYMPHOID
TISSUES
To further document the expression of NKp46 in human tissues,
we investigated by flow cytometry the distribution of NKp46+ cells
in various lymphoid and non-lymphoid organs. NKp46 was ana-
lyzed with respect to CD56. Consistent with published data (Freud
and Caligiuri,2006),CD56brightNKp46bright cells were abundant in
secondary lymphoid organs, such as the mesenteric lymph nodes
(MLN) and the iliac lymph nodes (ILN), while CD56dimNKp46dim
cells were predominant in the peripheral blood, the lung, and
the spleen (Figures 7A,B). Similar proportions of these two cell
subsets were detected in the gut (Figures 7A,B). Besides the
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FIGURE 4 | Distribution of NKp46+ cells in the gut. (A,B) Frozen sections
of human ileum (A,B) or of human colon (C,D) were stained with polyclonal
anti-NKp46 serum (green), anti-CD20 mAb (red), and anti-CD3 mAb (blue).
Nuclei were counterstained with Sytox (gray). Arrows indicate NKp46+CD3−
cells. LP, lamina propria. Scale bar=50µm. Data are representative of at least
two independent experiments performed on three distinct individuals.
FIGURE 5 | Staining with anti-NKp46 and anti-CD3 on human
colon. Frozen sections of human colon were stained with polyclonal
anti-NKp46 serum (green) and anti-CD3 mAb (blue). Nuclei were
counterstained with Sytox (gray). Scale bar=50µm. Inset
1=NKp46+CD3− in gut lamina propria; inset 2=NKp46+CD3− within
epithelial cell layer; inset 3=NKp46+CD3+ within epithelial cell layer.
One representative experiment performed on three distinct
individuals.
well-known dichotomy between CD56bright and CD56dim NK
cells, the use of NKp46 allowed us to identify CD56dimNKp46low
cells (Figure 7A). Within CD56+ cells this novel cell subset
was abundant in both ileum and colon, but rare, although
detectable, in the other lymphoid and non-lymphoid organs
studied (Figures 7A,B).
The low NKp46 expression in CD56dim cells was reminiscent
of CD117+RORγt+NKp46low ILCs detected in gut tissue sections

























































Tomasello et al. Mapping of human NKp46+ cells
FIGURE 6 | RORγt+ cells in the gut express low cell surface density of
NKp46. (A,B) Frozen sections of human colon were stained with (A)
polyclonal anti-NKp46 serum (green), anti-RORγt mAb (red), and anti-CD117
mAb (blue) or with (B) polyclonal anti-NKp46 serum (green), anti-RORγt
mAb (red), and anti-CD3 mAb (blue). Nuclei were counterstained with Sytox
(gray). Scale bar=50µm. Data are representative of at least three
independent experiments performed on three distinct individuals.
(Figure 6A). In both human and mouse, RORγt+ILCs express
high amounts of CD117 and CD127 (receptors for stem cell factor
and IL-7, respectively; Vivier et al., 2009; Sawa et al., 2010), while in
NK cells the expression of these cytokine receptors is restricted to
cell precursors (Freud and Caligiuri, 2006; Crellin et al., 2010).
In the spleen, lymph nodes, and gut, CD56dimNKp46low cells
enclosed up to 72% of CD117brightCD127bright cells (Figures 7C
and 8A,C). However, CD117−CD127− cells could also be
detected within CD56dimNKp46low cell subset (Figure 7C).
Within CD56dimNKp46dim cell, CD117brightCD127bright, and
CD117−CD127− cell proportions varied depending on the organ
analyzed, the latter being predominant in the spleen (Figures 7C
and 8A,C). In contrast, CD56brightNKp46bright were mainly
CD117−CD127− cells (up to 71% of cell subset) in all organs
analyzed (Figures 7C and 8A,C). Finally, we detected also a
minor fraction of CD117lowCD127low cells in CD56dimNKp46low,
CD56brightNKp46bright, and CD56dimNKp46dim cells subsets
(Figures 7C and 8).
In NK cells, CD94 is present on both CD56bright and
CD56dim cell subsets, but undetectable on earlier NK cell
maturation stages, such as stage 1 (CD34+CD117− cells), 2
(CD34+CD117+ cells), and 3 (CD34−CD117+ cells; Freud et al.,
2005). We then investigated the expression of CD94 with respect
to CD117 in CD56dimNKp46low, CD56brightNKp46bright, and
CD56dimNKp46dim cells subsets. As expected, CD94 was expressed
on CD117− cells (Figures 7D and 8B,D, red gate), but absent on
CD117bright cells of all the three subsets analyzed (Figures 7D and
8B,D, green gate). Yet, CD94 was expressed on CD117lowCD127low
cell subset (Figures 7C and 8, blue gate).
In conclusion, our results highlight an heterogeneity of
human CD56dim cells expressing low (NKp46low) to intermediate
(NKp46dim) amounts of NKp46 at their cell surface. These hetero-
geneous populations include CD117brightCD127brightCD94− cells
and CD117−CD127−CD94+ cells, phenotypically reminiscent of
RORγt+ILC and cNK cells, respectively.
CHARACTERIZATION OF SPLENIC CNK CELL AND RORγt+ ILC CELL
SUBSETS
As our results showed that the cell surface density of
NKp46 varies between human RORγt+ ILC and cNK, we
decided to pursue our phenotypic analysis by comparing well-
defined subsets of these two cell lineages for their cell sur-
face expression of NKp46. In humans cNK were defined
as lineage−CD56+CD117−CD127−RORγt− cells, while adult
RORγt+ ILCs,enclosing Lymphoid Tissue inducers (LTi)-like cells,
were characterized as lineage−CD117brightCD127brightRORγt+
cells and included a CD56+ cell fraction (Cupedo et al.,
2009; Crellin et al., 2010). By combining CD56 and CD117
staining, we discriminated within CD45+CD3−CD19− splenic
cells the following five populations: (1) CD56−CD117bright
cells; (2) CD56dimCD117bright cells; (3) CD56brightCD117low
cells; (4) CD56brightCD117− cells; (5) CD56dimCD117−cells
(Figure 9A). CD56−CD117bright and CD56dimCD117bright cells
were RORγt+CD127brightNKp30+, but they do not express
NKR such as CD94, CD16, and KIR. The NCR NKp44 was
expressed on a fraction of CD56dimCD117bright cells (Figure 9B).
In contrast, CD56brightCD117− and CD56dimCD117−cells were
mainly RORγt−CD127− NKp30lowNKp44− and expressed CD94,
CD16, and KIR according to the well-known phenotypic
profiles of peripheral CD56bright and CD56dim cNK cell
subsets, respectively (Figure 9B). CD56brightCD117low were
RORγt−CD127low and expressed a phenotypic profile similar to
that of CD56brightCD117− cells for the NKp30, NKp44, CD94,
CD16, and KIR markers (Figure 9B).
We then analyzed the cell surface expression of NKp46 on
splenic RORγt+ ILCs and cNK cell subsets. Consistent with our
previous findings (Figures 7 and 8), NKp46 was detectable at
low levels on both CD56− and CD56dim fractions of CD117bright
cells (Figure 9C). In contrast, NKp46 was expressed at high levels
on CD56brightCD117− cells and CD56dimCD117− cells, as well as
on CD56brightCD117low cells (Figure 9C). Nevertheless, a minor
fraction of NKp46low cells was detectable in all these three cell
subsets (Figure 9C). Altogether, these data confirm that NKp46 is
poorly expressed on RORγt+ ILCs, while it stains brightly most of
cNK cells.
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FIGURE 7 | Surface expression of CD56 and NKp46 identifies three
distinct cell subsets in human lymphoid and non-lymphoid organs.
(A) Flow cytometry analysis of cells isolated from the indicated human
organs, by gating on CD45+CD3−CD19− cells. Numbers (mean±SEM) in
quadrants indicate percentages of cells. Data are representative of at least
three independent experiments. (B) Proportions (mean±SEM) of indicated
cell subsets within CD56+CD45+CD3−CD19− cells. N =6–8 for PBMC,
spleen, lung, ileum, and colon; N =2–3 for ILN and MLN. (C) Flow cytometry
analysis of cell surface expression of indicated cytokine receptors on splenic
CD56dimNKp46low, CD56brightNKp46bright, and CD56dimNKp46dim cell subsets.
Data are representative of at least three independent experiments. Red gate,
CD117−CD127− cells; blue gate, CD117lowCD127low cells; green gate,
CD117brightCD127bright cells. (D) Flow cytometry analysis of CD94 and CD117
expression on indicated cell subsets of CD45+CD3−CD19− splenocytes.
Numbers in quadrants indicate percentages of cells. One experiment
representative of three. Red cells were gated on CD117−CD127− cells; blue
cells were gated on CD117lowCD127low cells; green cells were gated on
CD117brightCD127bright cells.
CHARACTERIZATION OF GUT cNK CELL AND RORγt+ ILC CELL SUBSETS
To further characterize RORγt+ ILC cell and cNK cell
subsets present in the gut, we performed genome-wide
expression profiling of sorted CD56−CD117brightCD127bright
cells and CD56+CD117−CD127− cells (thus containing
both CD56brightCD117− and CD56dimCD117− cells) isolated
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FIGURE 8 | Expression of CD127, CD117 and CD94 on CD56+ cell subsets
of human lymph nodes and ileum. (A–D) Flow cytometry analysis of cell
surface expression of indicated molecules on cells isolated from indicated
organs. Red gate, CD117−CD127− cells; blue gate, CD117lowCD127low cells;
green gate, CD117brightCD127bright cells. (A,B), Mesenteric lymph node cells;
(C,D), Ileum LPC.
from human colon. Genes upregulated at least twofold in
CD56−CD117brightCD127bright cells with respect to CD56+
CD117−CD127− cells included IL-22, KIT, TNFSF11, IL1R1,
RORC, and IL7R, thus encoding molecules well-known as
involved in RORγt+ ILC development and function (Table 1;
Table 2 in Supplementary Material). In contrast, genes upreg-
ulated at least twofold in CD56+CD117−CD127− with respect
to CD56−CD117brightCD127bright cells encompassed GZMA,
GZMK, GZMH, IFNG, CCL4, CCL5, encoding key molecules reg-
ulating NK cell cytotoxicity and cytokine secretion (Table 1; Table
3 in Supplementary Material). Phenotypic analysis in the spleen
and genome-wide profiling in the gut thus allowed us to unequiv-
ocally assign CD56−CD117bright and CD56dimCD117bright to the
RORγt+ ILCs and CD56brightCD117− cells and CD56dimCD117−
cells to cNK cells.
DISCUSSION
The characterization of NK cells according to their anatomical
localization is paramount to unveil the physiological role of these
unconventional lymphocytes. By using the NKp46 NK cell marker,
we reported here an extensive analysis of NKp46+ cell localization,
frequency, and phenotype in lymphoid and non-lymphoid tissues
isolated from human healthy donors.
Our work shows that the use of NKp46 for the identification
of human cNK cells presents important advantages with respect
to other NK cell markers, such as CD56. Indeed, in gut sections
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FIGURE 9 | Phenotypic profiles of splenic cNK and RORγt+ILC cell
subsets. (A) Flow cytometry analysis of CD56 vs. CD117 expression on
splenic human cells, by gating on CD45+CD3−CD19− cells. Data are
representative of at least three independent experiments. Numbers
indicate the following cell subsets: (1) CD56−CD117bright cells; (2)
CD56dimCD117bright cells; (3) CD56brightCD117low cells; (4) CD56brightCD117−
cells; (5) CD56dimCD117− cells. (B,C) Expression of the indicated ILC or NK
cell markers (B) or of the NKp46 cell marker (C) on indicated splenic cell
subsets defined as in (A). Black line, specific staining; dashed line, isotype
control staining in (B) or staining on CD56−CD117− cells in (C). Numbers in
(C) represent the mean fluorescence intensity of NKp46 expression in
indicated cell subsets.
CD56 staining on intestinal neural fibers prevented proper detec-
tion of hematopoietic CD3−CD56+ cells; hence NK cells could be
identified as CD3−NKp46+RORγt− cells. Moreover, with respect
to T lymphocytes, CD3+CD56+ cells were at least 30-times more
abundant than the few detectable CD3+NKp46+ cells in all organs
analyzed (Figure 3 and data not shown), thus confirming that
NKp46+ cells mainly consist of cNK cells. Altogether, our find-
ings indicate that, as already shown in other mammalian species
(Storset et al., 2004; Walzer et al., 2007b; Jozaki et al., 2010;
Connelley et al., 2011), the expression of NKp46 is a reliable
tool to identify cNK in human healthy tissues in histology and
flow cytometry. These expression data thus establish the basis for
analyzing quantitative and qualitative changes of NK cell compart-
ment that could be associated with various clinical conditions in
humans.
Our analysis also revealed that, besides the well-characterized
CD56brightNKp46bright and CD56dimNKp46dim subsets of cNK
cells, CD56dim cells include cells with low expression
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Table 1 | Example of genes upregulated at least twofold in the


















IL-22 10,8 GNLY 4,8
KIT 3,1 GZMA 3,9
TNFSF11 3,0 IFNG 3,9
IL1R1 2,9 GZMK 3,9
TNFRSF11A 2,7 CCL4 3,6
RORC 2,6 EOMES 3,1
TNFSF4 2,4 GZMH 2,6
IL7R 2,3 CCL5 2,4
of NKp46 phenotypically related to the RORγt+ ILCs
(CD56dimNKp46lowCD117brightCD127brightCD94−) or to the
NK cell lineage (CD56dimNKp46lowCD117−CD127−CD94+).
CD56dimNKp46lowCD117brightCD127brightCD94− cells expressed
RORγt. When isolated from gut, but not from spleen, these
cells were able to secrete IL-22 upon IL-23 stimulation (data
not shown). Accordingly, a RORγt+ ILC signature, including
genes such as RORC, IL-22, IL1R1, IL7R, KIT and conserved
since fetal life in mice (Reynders et al., 2011) was detected in
CD117brightCD127bright cells isolated from human colon (Table 1;
Table 2 in Supplementary Material). Altogether, these findings
support the classification of CD117brightCD127brightCD94− cells
within CD56dimNKp46low cells as RORγt+ ILCs. Consistent with
our data, RORγt+ILCs present in human tonsils, lymph nodes, and
gut harbor low NKp46 cell surface expression (Cella et al., 2009;
Cupedo et al., 2009; Crellin et al., 2010; Takayama et al., 2010).
In contrast, the CD117−CD127−CD94+ cells identified within
CD56dimNKp46low cells remain poorly characterized. Their cell
surface phenotype is rather consistent with their belonging to the
NK cell lineage. However, their position along NK cell maturation
stages is unclear. They could represent an immature CD94+ NK
cell subset harboring low amounts of NKp46. Alternatively, they
could include NK cells that downregulated NKp46 upon recep-
tor engagement. Further molecular and developmental studies are
required to disentangle their origin and function within NK cell
lineage.
Differently from what shown in mice (Satoh-Takayama et al.,
2008; Luci et al., 2009; Sanos et al., 2009), NKp46 cannot be used by
itself to identify NKR+ subsets of human RORγt+ILCs. These dif-
ferences could be related to both evolutionary and environmental
factors. Indeed, NKp46 is the only NCR expressed in murine cells,
while human cells can express other NCRs such as NKp44 and
NKp30. NKp30 was detectable, although at low levels, on both NK
and RORγt+ILCs, while NKp44 was found on a large fraction of
RORγt+ILCs, consistent with previous reports (Cella et al., 2009;
Cupedo et al., 2009; Crellin et al., 2010; Takayama et al., 2010).
Distinct NCRs could regulate RORγt+ILC functions in different
mammalian species. In mice, NKp46 is dispensable for IL-22 pro-
duction by RORγt+ILC (Satoh-Takayama et al., 2009). Indeed,
IL-22 production is detectable in RORγt+ILC since fetal life, early
before the acquisition of NKp46 expression, and is regulated by
IL-1-dependent, but commensal flora-independent mechanisms
(Reynders et al., 2011). It cannot be excluded that NCRs could be
involved in other RORγt+ILC functions. Adult RORγt+ILC can
regulate CD4+ T cell memory responses (Lane et al., 2012). In NK
cells, NKp46 participates to the tuning of effector function (Narni-
Mancinelli et al., 2012). Whether NKp46 or NKp44 are involved in
these functions in NKR+RORγt+ILC remains to be investigated,
as well as the NKp46 and NKp44 cellular ligands which remain to




All organ samples were obtained from cadaveric heart-beating
donors at the end of the procedure of graft harvesting. Accord-
ing to the French law (articles L. 1232-3, L. 1241-5 et L. 1241-6
du code de la santé publique), all the procurements of samples
were done in accordance with the rules of the Agency of the Bio-
medicine in France (Agence de la biomédecine), which approved
and was informed of the entire experimental protocol (Protocol
N ˚=PFS08-004). The Agency also verified the absence of oppo-
sition to donation of tissues for scientific issues, from the donor
(registry) or his/her family. All samples were stored in cold phos-
phate buffer (PB) immediately after procurement. No information
about the donor identity was available. All clinical and biological
tools were accessible thanks to the donor chart available at the
Agency of the Biomedicine.
Colon fragments used for extraction of intestinal cell subsets
used for microarrays were obtained from patients affected by colon
cancer that underwent surgical resection of segments of intestine.
The biological specimens of colon used for the present study were
“free” of any diseases, as assessed by the Unit of Pathology of the
Istituto Clinico Humanitas, Milan, Italy. In particular, our patholo-
gists evaluated the following histological features within the resec-
tion margins: edema, inflammation, lymphoid aggregates, pyloric
metaplasia, fibrosis, cryptitis and crypt abscesses, ulcers, granulo-
mas, villous shortening, mucin depletion, neuronal hyperplasia,
and transmural inflammation, cancer infiltrates. Gut specimens
with such characteristics were excluded from our study. Gut tis-
sue specimens were obtained in accordance with clinical protocols
approved by the Institutional Review Board (IRB) of Istituto Clin-
ico Humanitas, Milan, Italy. Each patient signed a consent form
that was approved by the above IRB that specified that the dona-
tion of gut specimens for this research project did not affect in any
way the diagnosis, the therapies and the prognosis of the disease.
IMMUNOFLUORESCENCE (HISTOLOGY)
Human spleen, small and large intestine portions were isolated
from human donors, extensively washed in PB, and then fixed
in PB supplemented with 4% paraformaldehyde (PFA, Electron
Microscopy Sciences, UK) for 2 h.
After three washes in PB, PFA-fixed organs were incubated
overnight in a PB supplemented with 30% sucrose. Tissues were
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then embedded in optimum cutting temperature compound
(Sakura Finetek), frozen in a bath of isopentane cooled on dry
ice, and cut in 8µm-thick sections. Human NKp46 staining was
then performed using polyclonal goat anti-human NKp46 (R&D
Systems, France), followed by Alexa488-conjugated donkey anti-
goat antibodies (Molecular Probes, France). Human CD20 stain-
ing was performed using monoclonal mouse anti-human (H1,
BD Pharmingen, France), followed by Alexa555-conjugated don-
key anti-mouse antibodies (Molecular Probes, France). Human
CD3ε staining was performed using mouse anti-human Alexa647-
conjugated mAb (BD Pharmingen, France). Goat IgG (R&D Sys-
tems, France) was used as isotype control for human NKp46
staining. Human CD206 staining was performed using mono-
clonal mouse anti-human (19.2, BD Pharmingen, France) fol-
lowed by Alexa555-conjugated donkey anti-mouse antibodies
(Molecular Probes, France). Human CD56 staining was performed
using monoclonal mouse anti-human (123C3, Abcam) followed
by Alexa488-conjugated donkey anti-mouse antibodies (Jackson
Immunoresearch) or Alexa555-conjugated donkey anti-mouse
antibodies (Molecular Probes, France). Human RORγt staining
was performed using monoclonal rat anti-mouse/human RORγt
(AFKJS-9, eBiosciences) followed by Cy3-conjugated donkey anti-
rat antibodies (Jackson Immunoresearch). Human CD117 stain-
ing was performed using polyclonal rabbit anti-human CD117
(Dako) followed by Alexa647-conjugated donkey anti-rabbit anti-
bodies (Jackson Immunoresearch). Purified mouse IgG2a isotype
control was used as isotype control for CD20 staining and Alexa
fluor 647-conjugated mouse IgG1 was used as isotype control for
CD3. Purified mouse IgG1 (BD Pharmingen) was used as iso-
type control for CD206 and CD56 staining. Purified rat IgG2a
(BD Pharmingen) was used as isotype control for RORγt staining.
Rabbit IgG (R&D Systems, France) was used as isotype control
for CD117 staining. Nuclear counterstaining was performed with
Sytox (Invitrogen, France).
After staining, slides were dried, mounted with Prolong Gold
(Invitrogen, France) and examined under Zeiss LSM 510 confocal
microscope (Zeiss). Image processing was performed with Zeiss
LSM and Adobe Photoshop softwares.
CELL PREPARATION AND STIMULATION
Peripheral Blood Mononuclear Cells (PBMC) were enriched from
total peripheral blood upon Ficoll gradient. Spleens were mechan-
ically disrupted, then splenocytes were enriched upon Ficoll gradi-
ent. MLN and ILN cells were obtained after mechanical disruption.
For preparation of cells from ileum and colon fragments, first
we removed muscularis mucosae, then fragments were carefully
washed in PBS 1×. After washing, gut pieces were cut into frag-
ments of 2 cm-length and treated 3–4 times with PBS containing
5 mM EDTA (Gibco, France), 15 mM HEPES (Gibco, France),
and 10% FCS at 37˚C at 200 rpm for 20 min, in order to remove
intraepithelial cells (IEC). After IEC extraction, intestinal pieces
were washed once in RPMI 10% FCS, then minced. Lamina pro-
pria cells (LPC) were obtained by incubating three times the
intestinal pieces with RPMI 10% FCS 15 mM HEPES (Gibco,
France) containing 300 UI/ml of collagenase type VIII (Sigma
Aldrich, France) at 37˚C at 200 rpm for 15 min. LPCs were then
enriched upon Percoll (Amersham-Pharmacia, France) gradient
centrifugation. Lung fragments were minced, then digested as for
gut LPC obtention. At the end of enzymatic digestions, cells were
enriched upon Ficoll gradient.
FLOW CYTOMETRY
Cells were incubated with normal mouse serum (2µl/sample)
in the presence of different combination of following mAbs:
FITC-conjugated anti-CD94 or anti-CD16 (both from BD
Biosciences); PE-conjugated anti-NKp46, anti-NKp44 or anti-
NKp30, or a mix of PE-conjugated anti-CD158a,h, anti-
CD158b,j, and anti-CD158e1,e2 (all from Beckman Coulter);
PerCP-Cy5.5-conjugated anti-CD3 (BD Biosciences) and PerCP-
Cy5.5-conjugated anti-CD19 (Biolegend), PE-Cy7-conjugated
anti-CD117 (Beckman Coulter), APC-conjugated CD56 (Beck-
man Coulter), Alexa700-conjugated anti-CD45 (Biolegend),
and eFluor450-conjugated anti-CD127 (eBiosciences). FITC-
conjugated, PE-conjugated and PE-Cy7-conjugated isotype-
matched controls were from Beckman Coulter or BD Biosciences,
while e450Fluor-conjugated isotype-matched control was from
eBiosciences. After 30 min of incubation at 4˚C, samples were
washed once and fixed 10 min in PBS 1× containing 2% of
paraformaldehyde. Samples were then washed in PBS 1×, resus-
pended in PBS 1× BSA 0.5%. Intracellular staining with anti-
mouse/human RORγt-PE (clone AFKJS-9, eBioscience, France)
was performed using the Foxp3 Fixation/Permeabilization kit
(eBioscience, France), according to the manufacturer indications.
Samples were run either on FACS Canto II or on LSRII cytome-
ters (BD Biosciences, France) and analyzed by using Flow Jo 9.0.2
software (Tree Star Inc.).
MICROARRAY ANALYSIS
Lamina propria cells were isolated from macroscopically unaf-
fected areas of colon of patients with colon cancer. Colonic
CD56−CD117brightCD127bright cells and CD56+CD117−CD127−
cells were sorted and immediately lysed in RLT buffer supple-
mented with 10% β-mercaptoethanol (Quiagen, France). Lysates
of three distinct donors were pooled and RNA was isolated
by using RNAeasy Microkit (Quiagen, France). Duplicates were
performed for each cell type. cRNA were obtained after dou-
ble amplification using the MessageAmp II aRNA Amplification
Kit (Ambion, France). cRNA were then hybridized on Human
Genome HG_U133+2.0 Affymetrix chips. Chip images were gen-
erated using Affymetrix AGCC 3.2 software, then expression data
were extracted and normalized using Affymetrix Expression con-
sole 1.1 with the algorithm RMA. Data obtained were expressed
as log2. Raw and normalized data have been deposited in the GEO
Database under reference number GSE41469. We selected 12278
probesets out of 54675 as “present,” when the probeset signal for
at least one out of four samples was≥ 6.5. For genes with multiple
probesets, we selected the probeset giving the highest signal (8027
probesets out of 12278). Finally, we selected the probesets hav-
ing linear fold changes≥ 2 in all possible replicate comparisons
between the two cell subsets analyzed.
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Tables 2 and 3 | Lists of genes upregulated in comparison between cNK vs.
ROR ILC. Gene represented were upregulated at least twofold in CD56−
CD117brightCD127bright cells with respect to CD56+CD117−CD127− cells (Table 2)
or in CD56+CD117−CD127− cells with respect to CD56−CD117brightCD127bright
cells (Table 3). Probeset ID, gene symbol, fold change values, representative
public ID, and extensive gene titles are indicated for each selected
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